Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.
Name:
Fernández Villalobos et al..pdf
Size:
1.849Mb
Format:
PDF
Description:
Open Access publication
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Fernández Villalobos, Nathalie VerónicaOtt, Jördis Jennifer
Klett-Tammen, Carolina Judith
Bockey, Annabelle
Vanella, Patrizio
Krause, Gérard
Lange, Berit
Issue Date
2021-06-30
Metadata
Show full item recordAbstract
Adjusting the protecting group strategy, from an alkyl ether to a bidentate ketal at the carbohydrate backbone of uridine, facilitates a switchable diastereoselective α- or β-C4'/C5'-spirocyclopropanation. Using these spirocyclopropanated nucleosides as key intermediates, we synthesized a variety of C4'-methylated d-ribose and l-lyxose-configured uridine derivatives by a base-mediated ring-opening of the spirocyclopropanol moiety. Investigations of antiviral activity against the human respiratory syncytial virus were carried out for selected derivatives, showing moderate activity.Citation
Syst Rev. 2021 Jun 30;10(1):194. doi: 10.1186/s13643-021-01732-3.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
BMCJournal
Systematic reviewsPubMed ID
34193261Type
ArticleLanguage
enEISSN
2046-4053ae974a485f413a2113503eed53cd6c53
10.1186/s13643-021-01732-3
Scopus Count
The following license files are associated with this item:
- Creative Commons
Related articles
- SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
- Authors: Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N
- Issue date: 2021 Sep 2
- Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
- Authors: Reis S, Metzendorf MI, Kuehn R, Popp M, Gagyor I, Kranke P, Meybohm P, Skoetz N, Weibel S
- Issue date: 2022 Sep 20
- Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.
- Authors: Burton JK, Craig L, Yong SQ, Siddiqi N, Teale EA, Woodhouse R, Barugh AJ, Shepherd AM, Brunton A, Freeman SC, Sutton AJ, Quinn TJ
- Issue date: 2021 Nov 26
- Antibody tests for identification of current and past infection with SARS-CoV-2.
- Authors: Fox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, Hettiarachchi D, Mathangasinghe Y, Weeratunga P, Wickramasinghe D, Bergman H, Buckley BS, Probyn K, Sguassero Y, Davenport C, Cunningham J, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Struyf T, Van den Bruel A, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Deeks JJ, Cochrane COVID-19 Diagnostic Test Accuracy Group
- Issue date: 2022 Nov 17
- SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
- Authors: Hirsch C, Park YS, Piechotta V, Chai KL, Estcourt LJ, Monsef I, Salomon S, Wood EM, So-Osman C, McQuilten Z, Spinner CD, Malin JJ, Stegemann M, Skoetz N, Kreuzberger N
- Issue date: 2022 Jun 17